Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Lidocaine vs TPVB for Recovery After Breast Cancer Surgery
NCT07823244Not yet recruiting
- Sponsor
- Mahidol University
- Start
- Oct 2026
- Primary completion
- Sep 2029
- Countries
- 1
01
Overview
Randomised, triple-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in pain (2 arms), sponsored by Mahidol University. Primary endpoint: Quality of recovery 15 score at 48 hours. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
pain
Beyond the preview
Go deeper on NCT07823244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07823244.